Catalent Launches OneXpress™ Solution to Accelerate Oral Dosage Products from Clinic to Launch

SOMERSET, N.J. – October 1, 2020 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its new OneXpress™ service for the integrated development, scale up and manufacturing of new oral solid dosage forms.

The OneXpress solution accelerates a program’s transition from early-phase development to commercial-ready manufacturing by leveraging Catalent’s phase-appropriate scale, technologies, extensive oral dose form network and expertise to reduce risk, complexity and cost between phases. By eliminating the need to transition projects between multiple service providers, duplication of tasks can be avoided, API consumption can be reduced, and drug products can reach patients faster.

Read the press release: https://www.catalent.com/catalent-news/catalent-launches-onexpress-solut...